Clinical Trials Browser

Phase 2 × Radiotherapy × Tumor-Agnostic × Clear all

NCT07018570 2025-08-26

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma

NCT07142200 2025-08-26

DECIDING

Phase 2 Not yet recruiting

Neoplasms

NCT05301881 2025-02-05

COSMO

Phase 2 Recruiting

Neoplasm Metastasis

NCT06112041 2023-11-01

The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

Phase 2 Not yet recruiting

Carcinoma

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Phase 2 Unknown

Neoplasms

NCT00176267 2023-06-01

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Phase 2 Completed

Carcinoma, Carcinoma, Squamous Cell

NCT00176254 2023-05-16

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

Phase 2 Completed

40 enrolled 9 charts

Carcinoma, Carcinoma, Squamous Cell

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Phase 2 Unknown

Neoplasms

NCT05115500 2021-11-10

ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)

Phase 2 Unknown

Carcinoma

NCT00389727 2019-07-15

Simultaneous Integrated Boost (SIB)- IMRT

Phase 2 Completed

Carcinoma, Squamous Cell

NCT00226239 2017-07-11

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

Phase 2 Completed

39 enrolled 10 charts

Neoplasms

NCT02674646 2016-02-04

ROSETTA

Phase 2 Unknown

Neoplasms

NCT01232374 2015-08-20

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Carcinoma, Squamous Cell

NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Phase 2 Withdrawn

Adenocarcinoma, Carcinoma